| |
INTENDED AUDIENCE
Retina specialists and ophthalmologists
LEARNING OBJECTIVES
Upon completion of this CME activity, the participant should be able to:
- Discuss the idea of value-based medicine and explain how interventions are quantified in this approach.
- Critique the current US health care system and identify strengths and weaknesses in the current national health plan.
- Define "time tradeoff" as it applies to value-based medicine.
ACCREDITATION AND DESIGNATION STATEMENTS
 Rush University Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Rush University Medical Center designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release Date: July 2009. The opinions or views expressed in this educational program are those of the participants and do not necessarily reflect the opinions or recommendations of Alcon Laboratories or Rush University Medical Center. The faculty may have included discussion on unlabeled uses of a commercial product or an investigational use of a product not yet approved for this purpose. Please consult the full prescribing information before using any medication mentioned in this educational program. This program has been produced in compliance with all ACCME Essential Areas and Elements and Accreditation Policies.
Expiration Date: July 30, 2010.
RUSH DISCLOSURE POLICY
It is the policy of the Rush University Medical Center Office of Continuing Medical Education to ensure that its CME activities are independent, free of commercial bias and beyond the control of persons or organizations with an economic interest in influencing the content of CME. Everyone who is in a position to control the content of an education activity must disclose all relevant financial relationships with any commercial interest (including but not limited to pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic) within the preceding 12 months. If there are relationships that create a conflict of interest, these must be resolved by the CME Course Director in consultation with the Office of Continuing Medical Education prior to the participation of the faculty member in the development or presentation of course content.
 
|
 |
CME COURSE DIRECTOR
Steven D. Schwartz, MD
Retina Division Chief
Jules Stein Eye Institute
Associate Professor of Ophthalmology
David Geffen School of Medicine
University of California, Los Angeles
Kirk H. Packo, MD
Director, Department of Ophthalmology
Rush University Medical Center
Chicago, Illinois
FACULTY
Gary C. Brown, MD, MBA
Professor of Ophthalmology at Jefferson Medical College and
Director of the Retina Service at Wills Eye Hospital in Pennsylvania
Melissa M. Brown, MD, RN, MN, MBA
Adjunct Senior Fellow at the Leonard David Institute of Health Economics at the University of Pennsylvania,
an Adjunct Assistant Professor at the University of Pennsylvania School of Medicine and a
former Associate Surgeon at the Cataract and Primary Eye Care Service at Wills Eye Hospital in Pennsylvania.
DISCLOSURES
Steven D. Schwartz, MD
Grant/Research/Support: None
Consultant: None
Speakers' Bureau: None
Stock Shareholder: None
Kirk H. Packo, MD
Grant/Research/Support: Alcon Laboratories, Inc
Consultant: None
Speakers' Bureau: None
Stock Shareholder: None
Gary C. Brown, MD, MBA
Grant/Research/Support: Genentech, Inc., Novartis, Allergan
Consultant:None
Speakers' Bureau: None
Stock Shareholder: Center for Value-Based Medicine
Melissa M. Brown, MD, RN, MN, MBA
Grant/Research/Support: None
Consultant: Allergan, Genentech, Inc., Pfizer, Inc., Novartis
Speakers' Bureau: None
Stock Shareholder: Director and Principal at the Center for Value-Based Medicine
|
|
